The weight loss industry is worth billions, and one of the most popular approaches is through medication – touted as a quick fix for shedding pounds and curbing cravings.
Pills and injections that help individuals lose weight and curb hunger pangs are often hailed as the Holy Grail to effortless fat-blasting that previously seemed unattainable.
A macro shot of syringe with needle. (Unsplash, Raghavendra Konkathi)
However, all weight-loss medications come with side effects.
Here are the latest diet drugs, how they work, and their side effects.
Wegovy
Semaglutide, marketed as Wegovy, is the latest drug approved by the National Institute for Health and Care Excellence (Nice) for routine use within the NHS. (Twitter)
Semaglutide, marketed as Wegovy, is the latest drug approved by the National Institute for Health and Care Excellence (Nice) for routine use within the NHS. It is a once-a-week weight-loss jab that stops you from feeling hungry. Semaglutide is intended to be used alongside a diet and exercise program for people living with higher body weight or obesity to improve their health.
It is not a lifestyle drug for already slim people who want to lose a few more pounds.
Semaglutide contains a compound that mimics a hormone called glucagon-like peptide-1 (GLP-1) and helps the pancreas release the right amount of insulin when blood sugar levels are high. It also makes you feel full because it slows down stomach emptying and suppresses appetite.
The drug has helped people shed up to 15 percent of their body weight. However, in clinical trials, people complained of side-effects including constipation, nausea, vomiting, headaches and diarrhea.
Studies show that people may regain weight once they stop taking the drug.
Ozempic
A surging number of residents in the United Arab Emirates are heading to health clinics, pharmacies and hospitals across the country trying to get their hands on diabetes injections such as Saxenda and Ozempic to use the medications for weight loss. (Twitter)
Ozempic is another drug containing semaglutide. It is taken weekly by injection into the thigh, arm, or stomach. It is similar to Wegovy and provides the drug Semaglutide in slightly lower doses but with similar weight-loss side effects
Ozempic is recommended for the treatment of type 2 diabetes and prescribed to help manage blood glucose levels in people with the condition. It is not intended as a weight-loss drug. It has become the worst-kept weight-loss secret in Hollywood as celebrities clamor to get hold of the drug to lose a few dress sizes for the red carpet.
Al Arabiya English reported last month how doctors in Dubai have revealed that interest has peaked in the drug after videos on TikTok and advertisements on Instagram promoted the medication as a miracle cure for stubborn fat – as residents are warned they cannot simply wander into a pharmacy to get their hands on the drug.
Xenical
Xenical is a branded version of the generic drug Orlistat
Xenical is a branded version of the generic drug Orlistat. It is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. It is taken one tablet with water before, during, or up to an hour after each of three daily meals. In trials, it has been shown to prevent up to one third of dietary fat from food being digested by the body. Mellor explains that it works by inhibiting gastric and pancreatic lipase enzymes that break down fat in the digestive system.
By preventing these enzymes from working properly, some of the undigested fat is eliminated from the body in stools. It is typically prescribed for 12 weeks, during which time you might expect to lose up to five percent of your body weight, in most cases that’s about three to seven kilograms.
The side effects of Xenical, however, are plentiful, according to The Times newspaper in the UK.
These drugs can cause oily diarrhea and flatulence. Other potential problems with use include headaches, anxiety, and menstrual disturbances.
Because it can lower the levels of fat-soluble vitamins A, D, E, and K absorbed by your body, it is recommended users take a multivitamin containing these nutrients, preferably at bedtime when the medication will not be used.
Alli
Alli, an over-the-counter Orlistat product, is another such pill that promises to help people lose weight
Alli, an over-the-counter Orlistat product, is another such pill that promises to help people lose weight by absorbing about 25 percent of the fat from food. However, common side effects include stomach pain and oily diarrhea, and it should not be taken for more than six months at a time. Alli is recommended for use by individuals with a BMI of 28 or higher, and a consultation with a pharmacist is required before taking it.
Mysimba
Another weight-loss pill is Mysimba.
Another weight-loss pill is Mysimba, which combines Naltrexone, an opiate antagonist, and Bupropion, an antidepressant. This combination is thought to target the central nervous system pathways responsible for hunger and eating, but it may also produce unwanted side-effects like dizziness, nausea, and drowsiness. In clinical trials, Mysimba has been shown to produce an average weight loss of five kilograms in a year, but it also has a high likelihood of causing people to quit due to side effects.
The roselle plant
Freeze-dried roselle flowers in a petri dish. The dish is being held in blue gloved hands. CREDIT: RMIT University
Scientists believe a supplement derived from a flower might be a miracle weight loss ingredient that can break down fat cells – without the side-effects of other dietary drugs, according to new research.
As Al Arabiya English reported earlier this month, the highly edible red roselle plant, native to Africa, is packed full of potent compounds that researchers in Australia think have “anti-obesity” properties and could lead to weight loss, according to a study published in the International Journal of Food Science and Technology.
Lab tests conducted by a team from RMIT University suggested that it hinders the body from forming new fat cells. The scientists treated human stem cells with phenolic extracts and hydroxycitric acid before they turned into fat cells. Cells exposed to hydroxycitric acid did not display any change in the fat content of adipocytes. On the other hand, cells treated with phenolic extracts had 95 percent less fat than other cells.
Australian scientists believe antioxidants in the plant stop the body from absorbing fat, leading it to being passed as waste instead of stored.
Crown Prince of Abu Dhabi meets with CEOs of leading Norwegian companies
H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, has met with a group of CEOs from leading Norwegian companies, as part of their participation in the UAE-Norway Investment Forum, held alongside his official visit to the Kingdom of Norway.
During the meeting, H.H. Sheikh Khaled bin Mohamed bin Zayed underscored the UAE leadership’s commitment to strengthening economic cooperation with its international partners.
He highlighted that investment in innovation and knowledge is a cornerstone for achieving sustainable development, noting that enhancing collaboration with Norwegian companies across key sectors will open new avenues for mutual economic growth between the two countries.
The UAE-Norway Investment Forum, taking place in Oslo, aimed to highlight available investment opportunities and strengthen trade relations between the UAE and Norway, fostering shared interests and supporting innovation and knowledge-based economic visions.
At the Indonesia International Book Fair 2024, TRENDS inaugurates 10th global office, releases four books
As part of its Asian research tour, partnership with Aletihad News Center, and
primary sponsorship of the Indonesia International Book Fair 2024, TRENDS
Research & Advisory inaugurated its office in Jakarta, marking its 10th location
worldwide. It also released four books in Indonesian.
The inauguration event was attended by ambassadors of the UAE, Bahrain, and
Jordan to Indonesia, chairpersons of the UAE and Indonesian Publishers’
Associations, the Director of TRENDS’ Jakarta office, and a group of researchers
and academics.
Speaking at the event, Dr. Mohammed Abdullah Al-Ali, CEO of TRENDS
Research & Advisory, stated that TRENDS’ international offices—set to reach 15
by the end of 2024—aim to enhance the Center’s research efforts and deepen its
role in disseminating knowledge, thus serving as a global knowledge bridge.
He emphasized, “At TRENDS, we believe in the importance of cooperation
between think tanks and prioritize this endeavor. We believe the TRENDS office in
Jakarta will enhance the exchange of knowledge and ideas between think tanks in
Asia and the Middle East, opening new horizons for collaboration in various
fields.”
Four books in Indonesian
As part of the Jakarta office’s inaugural activities, four books were released in
Indonesian, including the 11th and 12th books of the Muslim Brotherhood
Encyclopedia and Global Trends in AI and Automation and the Future of
Competition between Man and Machine: An Analytical Forward-looking Vision.
Hostility to Arab states
The 11th book of the Muslim Brotherhood Encyclopedia, The Concept of the State
According to the Muslim Brotherhood, highlights its hostile stance toward Arab
states since its inception. The group views them as an obstacle to its ascent to
power. It opposed the modern principles upon which these states were built,
considering them incompatible with the group’s unique interpretation of Islam,
which it claimed to embody exclusively.
Exclusion of nonconformists
The 12th book, The Muslim Brotherhood: Rejection of Tolerance and Exclusion of
Nonconformists, examines the Muslim Brotherhood’s stance towards
nonconformists, individuals, and entities. The book reveals the group’s binary view
of the world, categorizing others as allies or adversaries. It ties these relationships
to the Brotherhood’s internal power struggles and self-serving interests.
Global Trends in AI
The third book, Global Trends in AI, explores significant developments in AI and
its impact on various aspects of life, including the economy, society, and
governance. It also offers a comprehensive analysis of technological advancements
in AI, its applications across sectors, the ethical and social challenges it presents,
and its future trajectory.
Automation
The fourth book, Automation and the Future of Competition between Man and
Machine: An Analytical Forward-looking Vision, addresses the growing challenges
faced by the human workforce in the face of widespread automation and AI
applications. The book concludes that while automation presents a significant
challenge to the labor market, it simultaneously creates new opportunities. It
emphasizes the importance of preparing for this shift through skills development,
continuous education, and adopting economic and social policies that support the
workforce.
Prominent pavilion and active presence
The TRENDS’ pavilion at the Indonesia International Book Fair has attracted
numerous visitors, including academic researchers and officials, such as the
ambassadors of the UAE, Bahrain, Qatar, Jordan, and Turkey. Additionally,
chairpersons of Arab and Indonesian publishers’ associations, authors, publishers,
and students visited the pavilion. All were impressed with and praised TRENDS’ diverse, valuable publications. They also commended TRENDS’ active
international presence and ability to address global developments with rigorous
analytical research.
Dr. Mohammed Abdullah Al-Ali honored the esteemed guests, including
ambassadors of the UAE and Bahrain to Indonesia, Wedha Startesti Yudha,
Chairperson of the Indonesia International Book Fair Committee, Arys Hilman
Nugraha, Chairman of the Indonesian Publishers Association, and others,
presenting them with TRENDS’ publications and commemorative shields.
Additionally, he awarded TRENDS’ Research Medal to Ni Made Ayu Martini
Indonesian Deputy Minister of Marketing, Tourism and Creative Economy
It is worth noting that during its current Asian research tour, TRENDS announced
the launch of the TRENDS Research Medal, awarded to individuals who make
significant contributions to the development of scientific research and promote collaboration with TRENDS in strengthening a culture of research across various fields.
US determined to prevent full-scale war in Middle East, Joe Biden tells UNGA79
US President Joe Biden highlighted the US Administration’s determination to prevent a wider war that engulfs the entire Middle East region, noting that a diplomatic solution “remains the only path to lasting security to allow the residents from both countries to return to their homes on the border safely”.
In remarks he made today before the 79th Session of the United Nations General Assembly (UNGA79), the US President said, “Full-scale war is not in anyone’s interest,” adding that a diplomatic solution is still possible.
He also touched on “the rise of violence against innocent Palestinians on the West Bank”, and the need to “set the conditions for a better future”, which he said featured “a two-state solution, where the world — where Israel enjoys security and peace and full recognition and normalised relations with all its neighbours, where Palestinians live in security, dignity, and self-determination in a state of their own”.
President Biden underscored the ceasefire and hostage deal put forth by Qatar and Egypt, which the UN Security Council endorsed. He said, “Now is the time for the parties to finalise its terms, bring the hostages home,” adding that this would help ease the suffering in Gaza, and end the war.